Dr. Lu founded Arbor Vita Corporation in 1998 to develop novel therapeutics and diagnostics using PDZ proteins. Previously, he held various appointments at Stanford University’s School of Medicine. He has earned an M.D. (with honors) and an M.S. in microbiology and immunology from the University of Washington’s School of Medicine and a B.S. in biology from the California Institute of Technology (Caltech). Dr. Lu is also a board-certified dermatologist and completed his residency training at Stanford University’s School of Medicine.

Ahmed Abtew was the Minister of Industry in Ethiopia. Upon his departure, he served as the Chairman of the Commercial Bank of Ethiopia (largest bank in Ethiopia) and Teret, Amhara, Ethiopia. The Ethiopian Prime Minister, Abiy Ahmed, tasked him to headed up a think tank on Economic Development. Currently, he is completing his PhD in Economics at the University of Vienna.

Mr. Recine has over forty years of experience in high tech. After starting his career at Motorola, he joined Silicon Valley giant National Semiconductor in 1970 where his last position was Director of Sales Operations. In 1982 he then co-founded Flagship Software and later Marcon Sales Inc. where he served as CEO. In 1991, he became Vice President of Marketing for the Linear Technology Corporation until he retired in 1996, and in 2001, he was a Director of Ingenuus Corporation.

Mr. Recine received his B.S. in physics from the University of Windsor (Ontario, Canada) and his M.B.A. from Northeastern University. He currently serves on several non-profit boards.

Mr. Saxe spent almost 30 years with Hoffmann-LaRoche Inc. and is former Vice President of Licensing and Corporate Development and Head of Patent law. From 1989 to 1993, he became president and CEO of Synergen Inc., a biotechnology company. As president of Saxe Associates from 1993 to 1995, he served as a consultant to venture capital firms and biotechnology, diagnostic, and pharmaceutical companies. From 1995 to 1999, he was president of PDL  BioPharma (formerly Protein Design Labs).

Mr. Saxe received his B.S. in biochemical engineering from Carnegie Mellon University, his J.D. from George Washington University’s School of Law, and his LL.M. from New York University’s School of Law. He serves as a director for several public and private companies, including Durect Corporation, VistaGen Therapeutics, and SciClone Pharmaceuticals.

Dr. Mayhle is a physician, engineer, entrepeneur and investor, having launched his first company at age 15.

He is a partner in one of the top physician-owned radiology groups in the U.S. Prior to his medical career, he was lead engineer in the Materials Technology section of the Boeing Company, responsible for development of advanced composite materials.

Investment interests include biotech, real estate, and cryptocurrencies. Dr. Mayhle was one of the earliest investors in Arbor Vita and has been a major supporter in the years since. He has board experience in both the non-profit and for-profit sectors.

Dr. Mayhle received an M.D. with Highest Honors from the University of Washington School of Medicine, M.S. in Chemical Engineering from the University of Washington College of Engineering, and B.S. in Engineering Science from Seattle Pacific University.

Dr. Lu founded Arbor Vita Corporation in 1998 to develop novel therapeutics and diagnostics using PDZ proteins. Previously, he held various appointments at Stanford University’s School of Medicine. He has earned an M.D. (with honors) and an M.S. in microbiology and immunology from the University of Washington’s School of Medicine and a B.S. in biology from the California Institute of Technology (Caltech). Dr. Lu is also a board-certified dermatologist and completed his residency training at Stanford University’s School of Medicine.